Research Topics
Species | M S NieminenSummaryAffiliation: Helsinki University Central Hospital Country: Finland Publications
| Collaborators
|
Detail Information
Publications
Effect of treating periodontitis on C-reactive protein levels: a pilot studyKimmo Mattila
Department of Medicine, Divisions of Infectious Diseases and Cardiology, Helsinki University Central Hospital, Helsinki, Finland
BMC Infect Dis 2:30. 2002..We wanted to study if treatment of periodontitis can decrease the levels of these inflammatory markers...
Gender related differences in patients presenting with acute heart failure. Results from EuroHeart Failure Survey IIMarkku S Nieminen
Division of Cardiology, Department of Medicine, Helsinki University Central Hospital, Finland
Eur J Heart Fail 10:140-8. 2008..This analysis evaluates the gender differences in patients hospitalised for acute heart failure (AHF) in the EuroHeart Failure Survey II (EHFS)...
Oral levosimendan in patients with severe chronic heart failure --the PERSIST studyMarkku S Nieminen
Division of Cardiology, Helsinki University Central Hospital, Helsinki, Finland
Eur J Heart Fail 10:1246-54. 2008..Intravenous levosimendan improves symptoms in acutely decompensated heart failure...
Levosimendan compared with dobutamine in low output patientsM S Nieminen
Division of Cardiology, University Central Hospital, Helsinki, Finland
Minerva Anestesiol 69:258-63. 2003..Levosimendan produced haemodynamic responses that were unaffected by concomitant use of beta blockers...
Considerations on the efficacy and safety of levosimendan in ischemic heart failureMarkku S Nieminen
Division of Cardiology, University Central Hospital, 00290 Helsinki, Finland
Ital Heart J 4:39S-44S. 2003..No increase in arrhythmias is seen. The hemodynamic effects of levosimendan are dose-dependent and the current recommended doses are safe. No increase in mortality or any life-threatening arrhythmias have been observed...
EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of populationMarkku S Nieminen
Division of Cardiology, Department of Medicine, Helsinki University Central Hospital, Haartmaninkatu 4, PO Box 340, 00029 HUS, Finland
Eur Heart J 27:2725-36. 2006....
Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failureM S Nieminen
Helsinki University, Finland
J Am Coll Cardiol 36:1903-12. 2000..We sought to define the therapeutic dose range of levosimendan in patients with New York Heart Association class II-IV heart failure of ischemic origin...
Definition and epidemiology of acute heart failure syndromesMarkku S Nieminen
Division of Cardiology, Helsinki University Central Hospital, Helsinki, Finland
Am J Cardiol 96:5G-10G. 2005..The epidemiology of AHFS has been studied in large and small registries and surveys in both North America and Europe. The properties of the population of patients with acute HF are discussed in light of these data...
Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of CardiologyMarkku S Nieminen
Division of Cardiology, Helsinki University Central Hospital, Haartmaninkatu 4, 00290 Helsinki, Finland
Eur Heart J 26:384-416. 2005
[Diagnosis and treatment of acute heart failure. Guidelines of the European Society of Cardiology]Markku S Nieminen
Division of Cardiology, Helsinki University Central Hospital, Haartmaninkatu 4, 00290 Helsinki, Finland
Kardiol Pol 63:143-86; discussion 187-9. 2005
Associations between lipoproteins and the progression of coronary and vein-graft atherosclerosis in a controlled trial with gemfibrozil in men with low baseline levels of HDL cholesterolM Syvanne
Department of Medicine, Helsinki University Central Hospital, Helsinki, Findland
Circulation 98:1993-9. 1998....
Determinants of the severity and extent of coronary artery disease in patients with type-2 diabetes and in nondiabetic subjectsM Syvanne
Department of Medicine, Helsinki University Central Hospital, Finland
Coron Artery Dis 12:99-106. 2001....
Serum complement C3/C4 ratio, a novel marker for recurrent cardiovascular eventsAnil Palikhe
Division of Cardiology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland
Am J Cardiol 99:890-5. 2007..The relative increase in serum C3 protein and decrease in C4 protein could explain changes in the C3/C4 ratio...
The use of more than one inotrope in acute heart failure is associated with increased mortality: a multi-centre observational studyJuhani Rossinen
Divisions of Emergency Care and Cardiology Department of Internal Medicine, Helsinki, Finland
Acute Card Care 10:209-13. 2008..Although weakly supported by scientific evidence, according to guidelines the use of inotropes in acute heart failure is indicated in the presence of hypoperfusion refractory to fluid resuscitation...
Endothelial release of tissue-type plasminogen activator and ischemia-induced vasodilatation are linked in patients with coronary heart diseaseJ Sinisalo
Department of Medicine, Helsinki University Central Hospital, Finland
Blood Coagul Fibrinolysis 10:181-7. 1999....
The effect of prolonged doxycycline therapy on Chlamydia pneumoniae serological markers, coronary heart disease risk factors and forearm basal nitric oxide productionJ Sinisalo
Department of Medicine, Helsinki University Central Hospital, Finland
J Antimicrob Chemother 41:85-92. 1998..Thus extended doxycycline therapy did not affect C. pneumoniae antibodies or coronary heart disease risk factors. We conclude that doxycycline monotherapy may not be sufficient to eradicate chronic C. pneumoniae infection...
Heart rate variability and progression of coronary atherosclerosisH V Huikuri
Division of Cardiology, Department of Medicine and Biocenter of Oulu, University of Oulu, Finland
Arterioscler Thromb Vasc Biol 19:1979-85. 1999..HR variability provided information on progression of focal coronary atherosclerosis beyond that obtained by traditional risk markers of atherosclerosis...
Multifactorial cardiovascular disease prevention in patients aged 75 years and older: A randomized controlled trial: Drugs and Evidence Based Medicine in the Elderly (DEBATE) StudyT E Strandberg
Department of Medicine, Geriatric Clinic, and the Division of Cardiology, University of Helsinki, Helsinki, Finland
Am Heart J 142:945-51. 2001..The aim of the Drug and Evidence Based Medicine in the Elderly (DEBATE) study is to test the applicability and effectiveness of established CVD treatments in elderly patients...
Markers of renal function and acute kidney injury in acute heart failure: definitions and impact on outcomes of the cardiorenal syndromeJohan P E Lassus
Division of Cardiology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland
Eur Heart J 31:2791-8. 2010..However, definitions and prognostic impact of AKI in AHF have been variable. Cystatin C is a prospective new marker of AKI. The objective of this study was to investigate the use of cystatin C as a marker of early AKI in AHF...
Cystatin C, NT-proBNP, and inflammatory markers in acute heart failure: insights into the cardiorenal syndromeJ P E Lassus
Department of Medicine, Division of Cardiology, Helsinki University Central Hospital, Helsinki, Finland
Biomarkers 16:302-10. 2011..We evaluated the interactions between kidney function, cardiac stress, and various inflammatory cytokines in patients with acute heart failure (AHF). The effect on 1-year mortality was also assessed...
Clarithromycin reduces recurrent cardiovascular events in subjects without periodontitisSusanna Paju
Institute of Dentistry, University of Helsinki, and Department of Oral and Maxillofacial Diseases, Helsinki University Central Hospital, Helsinki, Finland
Atherosclerosis 188:412-9. 2006..Long-term clarithromycin therapy seems to be beneficial in prevention of recurrent cardiovascular events in non-periodontitis but not in periodontitis patients...
Two novel mutations in the beta-myosin heavy chain gene associated with dilated cardiomyopathySatu Kärkkäinen
Department of Medicine, Kuopio University Hospital, P O Box 1777, 70211 Kuopio, Finland
Eur J Heart Fail 6:861-8. 2004..Dilated cardiomyopathy (DCM) is familial in approximately 20-35% of cases of idiopathic DCM. Several mutations in the different sarcomere protein genes have been reported to cause DCM...
Relation of QT interval and QT dispersion to echocardiographic left ventricular hypertrophy and geometric pattern in hypertensive patients. The LIFE study. The Losartan Intervention For Endpoint ReductionL Oikarinen
Division of Cardiology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland
J Hypertens 19:1883-91. 2001..We assessed the relation of QT intervals and QT dispersion to echocardiographically determined left ventricular (LV) mass and geometry in a large population of hypertensive patients with ECG evidence of LVH...
Associations between interleukin-1 (IL-1) gene variations or IL-1 receptor antagonist levels and the development of type 2 diabetesK Luotola
Department of Medicine, Helsinki University Hospital, Helsinki, Finland
J Intern Med 269:322-32. 2011..We further examined whether genetic variants at the interleukin-1 (IL-1) locus would predict clinically incident diabetes...
The hemodynamic and pharmacokinetic interactions between chronic use of oral levosimendan and digoxin in patients with NYHA Classes II-III heart failureV P Harjola
Division of Emergency Care, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland
Int J Clin Pharmacol Ther 46:389-99. 2008..The aim of this exploratory study was to assess the hemodynamic and pharmacokinetic interactions between digoxin and oral levosimendan as well as the proarrhythmic potential of this combination in patients with chronic heart failure...
Serum homocysteine, creatinine, and glucose as predictors of the severity and extent of coronary artery disease in asymptomatic members of high-risk familiesP Pajunen
Hilsinki University Central Hospotal, Helsinki, Finland
Eur J Clin Invest 32:472-8. 2002..There has been no previous study to determine the severity and extent of coronary artery disease (CAD) in subjects with no diagnosis or symptoms of CAD at the time of the angiography...
Biodegradation of the copolymeric polylactide stent. Long-term follow-up in a rabbit aorta modelE M Hietala
Department of Surgery, Helsinki University Hospital, Helsinki, Finland
J Vasc Res 38:361-9. 2001..PLA96 may thus be a promising stent core material for small vessels in the future, although further investigation is needed to establish its final biocompatibility...
Impact of postprandial lipaemia on low-density lipoprotein (LDL) size and oxidized LDL in patients with coronary artery diseaseM Graner
Helsinki University Central Hospital, Helsinki, Finland
Eur J Clin Invest 36:764-70. 2006....
Clinical findings, outcome and treatment in patients > or = 75 years with acute myocardial infarctionMervi Kotamäki
Department of Medicine, Division of Cardiology, University of Helsinki, Finland
Eur J Epidemiol 18:781-6. 2003..Our aim was to characterize current clinical course, medication and invasive treatment in elderly patients with AMI, compare treatment between sexes and also with data from 1994...
Insulin resistance as predictor of the angiographic severity and extent of coronary artery diseaseMarit Graner
Department of Internal Medicine, Division of Cardiology, Helsinki University Central Hospital, Helsinki, Finland
Ann Med 39:137-44. 2007..Insulin resistance (IR) is frequently observed in patients with coronary artery disease (CAD). Aim. To examine the association between IR and severity and extent of CAD...
Serum homocysteine concentrations, gemfibrozil treatment, and progression of coronary atherosclerosisMikko Syvanne
Department of Medicine, Division of Cardiology, Helsinki University Central Hospital, P O Box 340, Haartmaninkatu 4, Helsinki, 00029 HUS, Finland
Atherosclerosis 172:267-72. 2004..The MTHFR genotype was not associated with extent or progression of coronary atherosclerosis. We conclude that gemfibrozil causes a significant elevation in tHcy levels, but the clinical relevance of this is unknown at present...
Association of paraoxonase-1 activity and concentration with angiographic severity and extent of coronary artery diseaseMarit Graner
Department of Internal Medicine, Division of Cardiology, Helsinki University Central Hospital, Helsinki, Finland
J Am Coll Cardiol 47:2429-35. 2006..The goal of this study was to examine the association between paraoxonase-1 (PON1) activity and concentration and the severity and extent of coronary artery disease (CAD)...
Clinical usefulness of bronchoalveolar lavage in heart transplant recipients with suspected lower respiratory tract infectionJuho T Lehto
Respiratory Diseases, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland
J Heart Lung Transplant 23:570-6. 2004..In this study, we evaluated the clinical impact and safety of bronchoscopy with BAL in heart transplant recipients...
Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNPJohan Lassus
Division of Cardiology, Department of Medicine, Helsinki University Central Hospital, Haartmaninkatu 4, POB 340, 00029 HUS, Helsinki, Finland
Eur Heart J 28:1841-7. 2007..We investigated the prognostic value of cystatin C in acute heart failure (AHF) in comparison to other markers of renal function and NT-proBNP...
Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular eventsPeter M Okin
Department of Medicine, Division of Cardiology, Cornell University Medical Center, New York, NY 10021, USA
JAMA 292:2343-9. 2004..However, the predictive value of changes in the magnitude of electrocardiographic LVH criteria during antihypertensive therapy remains unclear...
Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failureVeli Pekka Harjola
Division of Emergency Care, Department of Medicine, Helsinki University Central Hospital, PO Box 340, Helsinki 00029 HUS, Finland
Eur J Heart Fail 12:239-48. 2010..Acute heart failure (AHF) has a poor prognosis. We evaluated 3- and 12-month mortality in different clinical classes of AHF patients from 30 European countries who were included in the EuroHeart Failure Survey (EHFS) II...
Stimulated release of endothelin-converting enzyme is simultaneous with tissue-type plasminogen activator and decrease in coronary heart diseaseJuha Sinisalo
Department of Medicine, Division of Cardiology, Helsinki University Central Hospital, Helsinki, Finland
Scand Cardiovasc J 36:100-4. 2002..We examined whether shedding of endothelin-converting enzyme (ECE), a metalloprotease responsible for endothelin production, is concomitant with tissue-type plasminogen activator (t-PA), and how atherosclerosis affects ECE release...
Possibilities of multifactorial cardiovascular disease prevention in patients aged 75 and older: a randomized controlled trial: Drugs and Evidence Based Medicine in the Elderly (DEBATE) StudyTimo E Strandberg
Department of Medicine, Geriatric Clinic and Division of Cardiology, University of Helsinki, Helsinki, Finland
Eur Heart J 24:1216-22. 2003..The aim of this pre-planned, first-year analysis of the Drugs and Evidence-Based Medicine in the Elderly (DEBATE) Study was to determine the feasibility of prevention efforts in elderly cardiovascular patients...
Apolipoprotein E polymorphism is associated with both carotid and coronary atherosclerosis in patients with coronary artery diseaseMarit Graner
Department of Internal Medicine, Division of Cardiology, Helsinki University Central Hospital, Haartmaninkatu 4, FIN 00290 HUCH, Helsinki, Finland
Nutr Metab Cardiovasc Dis 18:271-7. 2008..Therefore, the aim of the present study was to examine the association between apoE polymorphism and carotid intima-media thickness (IMT), and severity and extent of coronary artery disease (CAD)...
Predictive value of electrocardiographic QT interval and T-wave morphology parameters for all-cause and cardiovascular mortality in a general population sampleKimmo Porthan
Department of Cardiology, Helsinki University Central Hospital, Helsinki, Finland
Heart Rhythm 6:1202-8, 1208.e1. 2009..The predictive value of ECG QT interval for mortality in the general population has been weak. Only a few population studies on the predictive value of ECG T-wave morphology parameters for mortality have been reported...
Cardiac findings of reactive arthritis: an observational echocardiographic studyTimo Hannu
Department of Medicine, Helsinki University Central Hospital, HUCH, Finland
Rheumatol Int 21:169-72. 2002..Echocardiographic evaluation may be warranted if the acute ReA persists or has a prolonged course but is not recommended for routine use...
High prevalence of four long QT syndrome founder mutations in the Finnish populationAnnukka Marjamaa
Research Program in Molecular Medicine, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland
Ann Med 41:234-40. 2009..In the present survey, we sought to estimate the actual prevalence of the founder mutations and to determine their effect sizes in the general Finnish population...
Effect of 3 months of antimicrobial treatment with clarithromycin in acute non-q-wave coronary syndromeJuha Sinisalo
Helsinki University Central Hospital, Department of Medicine, Division of Cardiology, Finland
Circulation 105:1555-60. 2002..Coronary artery disease, an inflammatory disease, may be caused by infection. We investigated whether the antibiotic clarithromycin would reduce morbidity and mortality in patients with acute non-Q-wave coronary syndrome...
Late fields of the magnetocardiographic QRS complex as indicators of propensity to sustained ventricular tachycardia after myocardial infarctionP Korhonen
Division of Cardiology and the BioMag Laboratory, Helsinki University Central Hospital, Finland
J Cardiovasc Electrophysiol 11:413-20. 2000..Magnetocardiographic (MCG) mapping is a new method to record cardiac signals. This study examined the association of MCG late fields with the propensity to sustained ventricular tachycardia (VT) after myocardial infarction (MI)...
Effect of age and body weight on neurohumoral variables in healthy Cavalier King Charles spanielsA S Eriksson
Department of Clinical Veterinary Sciences, Faculty of Veterinary Medicine, Helsinki University, Finland
Am J Vet Res 62:1818-24. 2001..The increased plasma concentrations of NT-ANP (but not BNP) and P-NN with aging reflect neurohumoral physiologic changes that must be distinguished from pathologic changes in patients with heart failure...
Periodontopathogen- and host-derived immune response in acute coronary syndromeH Alfakry
Institute of Dentistry, University of Helsinki, Helsinki, Finland
Scand J Immunol 74:383-9. 2011..Despite the observed cross-reactivity in the systemic IgG-class antibody response to HSP60 and A. actinomycetemcomitans, the pathogen carriage in saliva or the periodontal status did not affect the HSP60 antibody levels in ACS patients...
Prognostic role of pro- and anti-inflammatory cytokines and their polymorphisms in acute decompensated heart failureKati H Miettinen
Department of Medicine, Kuopio University Hospital, Kuopio, Finland
Eur J Heart Fail 10:396-403. 2008..Cytokines play an important role in chronic heart failure (HF), but little is known about their involvement in acute decompensated heart failure (ADHF)...
Home-measured blood pressure is more strongly associated with atherosclerosis than clinic blood pressure: the Finn-HOME StudyTeemu Niiranen
Department of Health and Functional Capacity, National Public Health Institute, Helsinki, Finland
J Hypertens 25:1225-31. 2007..Other risk factors associated with carotid atherosclerosis were also investigated...
Pulse pressure and effects of losartan or atenolol in patients with hypertension and left ventricular hypertrophyFrej Fyhrquist
Helsinki University Central Hospital, Department of Medicine, and Minerva Institute for Medical Research, Helsinki, Finland
Hypertension 45:580-5. 2005..The risks in the losartan group also increased with increasing pulse pressure quartile, but were lower than those in the atenolol group, and were not significant...
Effects of levosimendan on the energy balance: preclinical and clinical evidenceMarkku S Nieminen
Division of Cardiology, Helsinki University Central Hospital, Helsinki, Finland
J Cardiovasc Pharmacol 53:302-10. 2009..Moreover, levosimendan-evoked KATP channel opening may possess favorable effects on mitochondrial adenosine triphosphate synthesis conferring cardioprotection during ischemic insults...
Eight-year safety follow-up of coronary artery disease patients after local intracoronary VEGF gene transferM Hedman
Department of Medicine, Kuopio University Hospital, Kuopio, Finland
Gene Ther 16:629-34. 2009..85), cancer (1 vs 4 vs 2; P=0.38) or diabetes (2 vs 2 vs 2; P=0.97) did not differ between the groups. Local intracoronary VEGF gene transfer is safe and does not increase the risk of MACE, arrhythmias, cancer, diabetes or other diseases...
Relation of inflammation to vascular function in patients with coronary heart diseaseJ Sinisalo
Department of Medicine, Division of Cardiology, The Helsinki University Central Hospital, Meilahti 15krs, Haartmaninkatu 4, FIN 00290, Helsinki, Finland
Atherosclerosis 149:403-11. 2000..It is possible that endothelial dysfunction in coronary heart disease patients is related to the chronic inflammation or infection coexisting with atherosclerosis...
QRS duration and QT interval predict mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention for Endpoint Reduction in Hypertension StudyLasse Oikarinen
Department of Medicine, Division of Cardiology, Helsinki University Central Hospital, Haartmaninkatu 4, 00290 Helsinki, Finland
Hypertension 43:1029-34. 2004....
Short-term electrophysiological effects of losartan, bisoprolol, amlodipine, and hydrochlorothiazide in hypertensive menKimmo Porthan
Helsinki University Central Hospital, Helsinki, Finland
Ann Med 41:29-37. 2009..Hypertension-induced left ventricular structural remodelling associates with repolarization abnormalities. We investigated if antihypertensive drugs can modulate ventricular repolarization...
[Executive summary of the guidelines on the diagnosis and treatment of acute heart failure]Markku S Nieminen
Division of Cardiology, Helsinki University Central Hospital, Helsinki, Finland. markku.nieminen.hus.fi
Rev Esp Cardiol 58:389-429. 2005
Common candidate gene variants are associated with QT interval duration in the general populationA Marjamaa
Research Program in Molecular Medicine, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland
J Intern Med 265:448-58. 2009..As 30-40% of the QT-interval variability is heritable, we tested the association of common LQTS and NOS1AP gene variants with QT interval in a Finnish population-based sample...
Heart transplantation in repaired transposition of the great arteriesA L Harjula
Department of Thoracic and Cardiovascular Surgery, Helsinki University Central Hospital, Finland
Ann Thorac Surg 46:611-4. 1988..Six months after operation, the patient is doing better than ever before in his life. Our findings suggest that a complicated conotruncal development does not preclude cardiac transplantation...
Cholesterol efflux capacity in vitro predicts the severity and extent of coronary artery disease in patients with and without type 2 diabetesP Pajunen
Department of Medicine, Helsinki University Central Hospital, Finland
Scand Cardiovasc J 35:96-100. 2001..In the diabetic group this association was independent of LpA-I levels, suggesting impaired antiatherogenic potential of these particles in type 2 diabetic patients...
Effect of ibopamine on the failing heart at rest and during isometric exercise: a noninvasive studyJ Partanen
First Department of Medicine, University Central Hospital, Helsinki, Finland
Clin Cardiol 11:15-22. 1988..Neither urine volume nor body weight changed. Side effects were mild except for tachycardia of one patient.(ABSTRACT TRUNCATED AT 250 WORDS)..
Lymphotoxin alpha LTA+496C allele is a risk factor for periodontitis in patients with coronary artery diseaseA Palikhe
Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland
Tissue Antigens 71:530-7. 2008..56; 95% CI = 1.05-2.30; P = 0.026) remained as significant risk factors for periodontitis. In conclusion, the major finding of this study is that the LTA+496C allele is associated with periodontitis in patients with CAD...
Human MHC region harbors both susceptibility and protective haplotypes for coronary artery diseaseA Palikhe
Division of Cardiology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland
Tissue Antigens 69:47-55. 2007..46; 95% CI 0.24-0.88; P = 0.02) or together with the haplotype LTA+253a-LTA+633g-C4A3-C4B1 (OR 0.36; 95% CI 0.22-0.57; P = 0.00001). In conclusion, human MHC region harbors genes that protect from and predispose to CAD...
Regression of electrocardiographic left ventricular hypertrophy predicts regression of echocardiographic left ventricular mass: the LIFE studyP M Okin
Department of Medicine, Division of Cardiology, Weill Medical College of Cornell University, New York, NY 10021, USA
J Hum Hypertens 18:403-9. 2004..Compared with progression of ECG LVH, regression of the Cornell product ECG LVH is associated with greater reduction in LV mass and a greater likelihood of regression of anatomic LVH...
Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OPTIMAAL experienceMika Lehto
Division of Cardiology, Helsinki University Central Hospital, Helsinki, Finland
Eur Heart J 26:350-6. 2005..The present study aimed to determine the frequency and the impact on clinical outcome of atrial fibrillation (AF) in patients with acute myocardial infarction (AMI) and left ventricular dysfunction...
Relation of twelve-lead electrocardiographic T-wave morphology descriptors to left ventricular massLasse Oikarinen
Division of Cardiology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland
Am J Cardiol 90:1032-5. 2002
Is periodontal infection behind the failure of antibiotics to prevent coronary events?Susanna Paju
Institute of Dentistry, University of Helsinki and Department of Oral and Maxillofacial Diseases, Helsinki University Central Hospital, PO Box 63, 00014 Helsinki, Finland
Atherosclerosis 193:193-5. 2007..We discuss the systemic effects of periodontal infection and consider studies to test our hypothesis, which offers a novel viewpoint for discussion of antibiotics in coronary-disease prevention...
Relation of QT interval and QT dispersion to regression of echocardiographic and electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan Intervention For Endpoint Reduction (LIFE) studyLasse Oikarinen
Division of Cardiology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland
Am Heart J 145:919-25. 2003..Experimentally, regression of LVH normalizes ventricular electrophysiology...
Chlamydia pneumoniae DNA is present in peripheral blood mononuclear cells during acute coronary syndrome and correlates with chlamydial lipopolysaccharide levels in serumAnil Palikhe
Department of Medicine, Division of Cardiology, Helsinki University Central Hospital, Helsinki, Finland
Scand J Infect Dis 41:201-5. 2009..003). In conclusion, Chlamydia pneumoniae DNA is present during acute coronary syndrome and in the recovery period, but declines in stable state, suggesting a role of the bacterium in the acute phase of coronary syndrome...
Relationship of electrocardiographic repolarization measures to echocardiographic left ventricular mass in men with hypertensionKimmo Porthan
Department of Cardiology, Helsinki University Central Hospital, Finland
J Hypertens 25:1951-7. 2007..We studied whether electrocardiographic repolarization changes are already detectable in mild LVM increase associated with hypertension...
Beneficial effect of clarithromycin in patients with acute coronary syndrome and complement C4 deficienciesRiitta Paakkanen
Division of Cardiology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland
Scand Cardiovasc J 43:395-401. 2009..We sought to examine the role of complement component C4 deficiencies on the effect of antibiotic treatment in patients with acute coronary syndrome (ACS)...
Low normal level of protein C or of antithrombin increases risk for recurrent cardiovascular eventsK Markus Pelkonen
Department of Medicine, Division of Cardiology, Helsinki University Central Hospital, Helsinki, Finland
Blood Coagul Fibrinolysis 16:275-80. 2005..In conclusion, lower PC and AT values, even within the normal range, seem to be associated with elevated risk for recurrent cardiovascular events and shorter event-free time in acute coronary syndrome patients...
Electrocardiographic assessment of left ventricular hypertrophy with time-voltage QRS and QRST-wave areasL Oikarinen
Division of Cardiology, Helsinki University Central Hospital, Helsinki, Finland
J Hum Hypertens 18:33-40. 2004..732; P<0.001). In conclusion, the BSPM QRS area sum compared to 12-lead QRS area sum does not substantially improve LVH assessment. The 2-lead QRS area sum may improve ECG QRS area-based LVH assessment...
Change in pulse pressure/stroke index in response to sustained blood pressure reduction and its impact on left ventricular mass and geometry changes: the life studyVittorio Palmieri
Division of Cardiology, Department of Medicine, Weill Medical College of Cornell University, New York, NY, USA
Am J Hypertens 21:701-7. 2008..In cross-sectional data in hypertensive subjects, brachial pulse pressure (PP)/Doppler stroke index (SVi), (PP/SVi) correlates weakly but significantly with left ventricular (LV) mass and relative wall thickness (RWT)...
A novel mutation, Arg71Thr, in the delta-sarcoglycan gene is associated with dilated cardiomyopathySatu Kärkkäinen
Department of Medicine, University of Kuopio, Kuopio University Hospital, P O Box 1777, 70211 Kuopio, Finland
J Mol Med (Berl) 81:795-800. 2003..We conclude that the desmin and delta-sarcoglycan genes are not predominant disease-causing genes in patients with DCM in eastern Finland...
Left ventricular mass regression in the LIFE study: effect of previous antihypertensive treatmentGerard P Aurigemma
Department of Medicine, Division of Cardiology, University of Massachusetts Medical School, Worcester, Massachusetts, USA
Am J Hypertens 16:180-6. 2003..Accordingly, our aim was to study the relationship between prior treatment and both baseline and 1-year echocardiographic LV mass in subjects enrolled in the Losartan Intervention For Endpoint reduction (LIFE) study...
Heart failure in the elderly: how risky is it to be discharged?Markku S Nieminen
Eur J Heart Fail 10:222-3. 2008
Effects of losartan or atenolol in hypertensive patients without clinically evident vascular disease: a substudy of the LIFE randomized trialRichard B Devereux
Weill Medical College of Cornell University, New York, New York, USA
Ann Intern Med 139:169-77. 2003....
Progression of atherosclerosis is associated with variation in the alpha1-antitrypsin genePhilippa J Talmud
Centre for Cardiovascular Genetics, Department of Medicine, British Heart Foundation Laboratories, Rayne Building, Royal Free and University College Medical School, 5 University St, London WC1E 6JF, UK
Arterioscler Thromb Vasc Biol 23:644-9. 2003..Alpha1-Antitrypsin (AAT) protects elastic tissue and may play a role in atherogenesis. The association of atherosclerosis progression with common AAT variants was considered in 2 clinical trials...
Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) StudyPeter M Okin
Department of Medicine, Cornell University Medical Center, 525 East 68th St, New York, NY 10021, USA
Circulation 108:684-90. 2003..However, uncertainty persists as to how best to regress ECG LVH...
Coronary artery disease-associated locus on chromosome 9p21 and early markers of atherosclerosisNilesh J Samani
Department of Cardiovascular Sciences, University of Leicester, UK
Arterioscler Thromb Vasc Biol 28:1679-83. 2008..The effect of the locus on early markers of atherosclerosis is unknown. We examined its association with carotid intima-media thickness (CIMT) and brachial flow-mediated dilatation (FMD)...
Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE studyKristian Wachtell
Copenhagen County University Hospital, Glostrup, Denmark
J Hypertens 20:405-12. 2002....
Peroxisome proliferator-activated receptor alpha gene variants influence progression of coronary atherosclerosis and risk of coronary artery diseaseDavid M Flavell
Centre for Cardiovascular Genetics, Department of Medicine, Royal Free and University College of London Medical School, London, UK
Circulation 105:1440-5. 2002..Peroxisome proliferator-activated receptor alpha (PPARalpha) regulates the expression of genes involved in lipid metabolism and inflammation, making it a candidate gene for atherosclerosis and ischemic heart disease (IHD)...
A novel functional polymorphism in the PECAM-1 gene (53G>A) is associated with progression of atherosclerosis in the LOCAT and REGRESS studiesMohamed A Elrayess
The Centre for Cardiovascular Genetics, British Heart Foundation Laboratories, Royal Free and University College Medical School, University College London, Rayne Building, 5 University Street, UK
Atherosclerosis 168:131-8. 2003..These data demonstrate that the PECAM-1 gene is responsive to shear stress in vitro and that decreased PECAM-1 gene expression in 53A carriers may influence reduced progression of vessel stenosis in patients with coronary artery disease...
Progressive hypertrophy regression with sustained pressure reduction in hypertension: the Losartan Intervention For Endpoint Reduction studyRichard B Devereux
Department of Medicine, Weill Medical College of Cornell University, New York, New York 10021, USA
J Hypertens 20:1445-50. 2002..To examine the time course of left ventricular (LV) geometric response to blood pressure (BP) control during 2 years of systematic antihypertensive treatment...
Ethnic differences in electrocardiographic criteria for left ventricular hypertrophy: the LIFE study. Losartan Intervention For EndpointPeter M Okin
Department of Medicine, Weill Medical College of Cornell University, New York, New York 10021, USA
Am J Hypertens 15:663-71. 2002..However, the high mortality associated with LVH in African American patients makes more accurate ECG detection of LVH in these patients a clinical priority...
Losartan benefits over atenolol in non-smoking hypertensive patients with left ventricular hypertrophy: the LIFE studyHenrik M Reims
Department of Cardiology, Ullevaal University Hospital, Oslo, Norway
Blood Press 13:376-84. 2004..Smoking increased cardiovascular risk markedly in the LIFE study. The benefit of losartan vs atenolol is consistent with the overall conclusion of the LIFE study, although the treatment effect appeared largest in non-smokers...
Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension studyLars H Lindholm
Steno Diabetes Centre, Gentofte, Denmark
J Hypertens 20:1879-86. 2002..There has been uncertainty about the risk of new-onset diabetes in hypertensive individuals treated with different blood pressure-decreasing drugs...
Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudySverre E Kjeldsen
Department of Internal Medicine, Dividsion of Hypertension, University of Michigan, Ann Arbor, USA
JAMA 288:1491-8. 2002..046). Losartan decreased ECG-LVH more than atenolol (P<.001) and was better tolerated. CONCLUSION: These data suggest that losartan is superior to atenolol for treatment of patients with isolated systolic hypertension and ECG-LVH...
Combination of the electrocardiographic strain pattern and albuminuria for the prediction of new-onset heart failure in hypertensive patients: the LIFE studyPeter M Okin
Greenberg Division of Cardiology, Weill Medical College of Cornell University, New York, New York, USA
Am J Hypertens 21:273-9. 2008..Although albuminuria and the electrocardiographic (ECG) strain pattern each predict development of heart failure (HF), whether combining albuminuria and strain improves prediction of new HF is unclear...
Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE StudyKristian Wachtell
Department of Internal Medicine, Glostrup University Hospital, Glostrup, Denmark
Circulation 116:700-5. 2007..Sudden cardiac death (SCD) occurs more often in patients with ECG left ventricular (LV) hypertrophy. However, whether LV hypertrophy regression is associated with a reduced risk of SCD remains unclear...
Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: the Losartan Intervention For Endpoint reduction in hypertension studyJorge R Kizer
Weill Medical College of Cornell University, New York, NY, USA
Hypertension 45:46-52. 2005....
Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) studyKristian Wachtell
Department of Medicine, Glostrup University Hospital, Glostrup, Denmark
J Am Coll Cardiol 45:712-9. 2005..This study was designed to evaluate whether different antihypertensive treatment regimens with similar blood pressure reduction have different effects on new-onset atrial fibrillation (AF)...
Electrocardiographic strain pattern and prediction of new-onset congestive heart failure in hypertensive patients: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) studyPeter M Okin
Greenberg Division of Cardiology, Weill Medical College of Cornell University, New York, NY 10021, USA
Circulation 113:67-73. 2006..However, whether ECG strain is an independent predictor of new-onset congestive heart failure (CHF) in the setting of aggressive antihypertensive therapy in unclear...
Gender differences in the treatment and secondary prevention of CHD at population levelAnna Kattainen
Department of Health and Functional Capacity, National Public Health Institute, Helsinki and Turku, Finland
Scand Cardiovasc J 39:327-33. 2005..The aim of this study was to investigate the state of treatment and secondary prevention of CHD in a population-based sample and to analyze possible gender differences in different age groups...
Coronary heart disease: from a disease of middle-aged men in the late 1970s to a disease of elderly women in the 2000sAnna Kattainen
Department of Health and Functional Capacity, National Public Health Institute, Mannerheimintie 166, FI 00300 Helsinki, Finland
Eur Heart J 27:296-301. 2006..To analyse secular changes in the prevalence of coronary heart disease (CHD) and to assess changes in the burden of CHD at population level...
Aortic valve sclerosis and albuminuria predict cardiovascular events independently in hypertension: a losartan intervention for endpoint-reduction in hypertension (LIFE) substudyMichael H Olsen
Department of Internal Medicine, Glostrup University Hospital, Glostrup, Denmark
Am J Hypertens 18:1430-6. 2005..We aimed to investigate whether they predicted cardiovascular (CV) events independently in patients with hypertension and electrocardiographic left ventricular (LV) hypertrophy...
[Guidelines for the Diagnosis and Treatment of Chronic Heart Failure: executive summary (update 2005)]Karl Swedberg
Sahlgrenska Academy, , , Sweden
Rev Esp Cardiol 58:1062-92. 2005
Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) studyKristian Wachtell
Department of Medicine, Glostrup University Hospital, Glostrup, Denmark
J Am Coll Cardiol 45:705-11. 2005..We assessed the impact of antihypertensive treatment in hypertensive patients with electrocardiographic (ECG) left ventricular (LV) hypertrophy and a history of atrial fibrillation (AF)...
